Simple, Effective and Validated. VTE CASE Risk Assessment Score for Venous Thromboembolism in Metastatic Germ Cell Tumour Patients Before First‐Line Chemotherapy
Our VTE risk score is a handy tool for GCT patients before first-line CTH for metastatic disease. Outperforming KRS and PPS, it has a good discriminatory value, especially for identifying low-risk patients.
Authors
- Anna Macios (ORCID: https://orcid.org/0000-0002-4279-5441)
- I. Zastawna
- Grażyna Poniatowska
- Tomasz Demkow (ORCID: https://orcid.org/0000-0002-1737-4944)
- Paweł Wiechno (ORCID: https://orcid.org/0000-0002-4894-3273)
- Wojciech Michalski (ORCID: https://orcid.org/0000-0001-7746-0839)
Institutions
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1002/cam4.70295
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00